Losoxantrone
Overview of the chemotherapeutic agent Losoxantrone
| Losoxantrone | |
|---|---|
| [[File:|frameless|220px|alt=|]] | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Overview[edit | edit source]
Losoxantrone is a synthetic antineoplastic agent belonging to the class of anthrapyrazoles. It is primarily used in the treatment of various types of cancer, including breast cancer, leukemia, and lymphoma. Losoxantrone functions by intercalating into DNA, thereby disrupting the replication of cancer cells and inhibiting their proliferation.
Mechanism of Action[edit | edit source]
Losoxantrone exerts its effects by intercalating into the DNA double helix. This intercalation disrupts the DNA replication process, leading to the inhibition of topoisomerase II, an enzyme crucial for DNA repair and replication. By inhibiting this enzyme, Losoxantrone prevents the cancer cells from dividing and proliferating, ultimately leading to cell death.
Pharmacokinetics[edit | edit source]
Losoxantrone is administered intravenously and is known for its rapid distribution throughout the body. It is metabolized primarily in the liver and excreted through the biliary system. The drug has a relatively long half-life, allowing for sustained action against cancer cells.
Clinical Use[edit | edit source]
Losoxantrone is used in the treatment of various malignancies, including:
The drug is often used in combination with other chemotherapeutic agents to enhance its efficacy.
Side Effects[edit | edit source]
Common side effects of Losoxantrone include:
- Nausea and vomiting
- Myelosuppression, leading to decreased white blood cell count
- Cardiotoxicity, which may manifest as congestive heart failure
- Alopecia
Patients receiving Losoxantrone require regular monitoring of their cardiac function and blood cell counts to manage these side effects effectively.
Research and Development[edit | edit source]
Ongoing research is focused on improving the efficacy and safety profile of Losoxantrone. Studies are exploring its use in combination with novel agents and its potential role in treating other types of cancer.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
